Transpact Enterprises share price
BSE: 542765Healthcare Equipment & SuppliesSmall Cap
Transpact Enterprises Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2019
Last close ₹100.70up ₹4.70 (4.90%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹96.00.
30 Oct: open ₹100.70, high ₹100.70, low ₹100.70
52-week range of traded prices to 30 Oct 2026
₹81.47Low, 1 Sep 2026₹234.90High, 11 Mar 2026
- Under BSE's graded surveillance, stage 0, and long-term additional surveillance, stage I, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3.89 Cr4,863rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 45.07
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.32
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.11
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,000
Results
Standalone; ₹ crore.Transpact Enterprises half-yearly results
Half year to Mar 2026, against the half year before
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.09 Crdown 10.53%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹0.04 Crdown 25.10%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 43.5%
Revenue by half year
Peak revenue ₹0.38 Cr, half year to Sep 2022; lowest ₹0.00 Cr, half year to Sep 2023
Net profit by half year, a loss in red
- Net profit
- Loss
A loss in 2 of the 6 half years shown
| ₹ crore | Sep 2022 | Sep 2023 | Mar 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | 0.38 | 0.00 | 0.00 | 0.08 | 0.10 | 0.09 |
| Net profit | 0.02 | −0.05 | −0.06 | 0.05 | 0.05 | 0.04 |
| Net margin | 6.2% | – | – | 61.6% | 52.0% | 43.5% |
Standalone. The last eight half years, but for those filed as quarters, which are below. The latest is shaded.
| ₹ crore | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.38 | – | – | – | – | – | 0.00 |
| Net profit | −0.07 | – | – | – | – | – | −0.05 |
| Net margin | −17.2% | – | – | – | – | – | – |
Standalone. The quarters the company also filed in the same span. No results on record for the quarters to Jun 2023, Sep 2023, Dec 2023, Mar 2024 and Jun 2024.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.18 Crup 118.18%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.09 Crup 860.00%
- Net margin
- 48.0%
Revenue by year
Peak revenue ₹0.38 Cr, year to Mar 2023; lowest ₹0.00 Cr, year to Mar 2020
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 5 of the 7 years shown
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.03 | 0.15 | 0.38 | 0.00 | 0.08 | 0.18 |
| Net profit | −0.43 | −0.06 | −0.24 | −0.07 | −0.09 | 0.01 | 0.09 |
| Net margin | – | −256.2% | −160.6% | −17.2% | – | 10.9% | 48.0% |
Standalone. Years to March. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Financial services, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +6.5% | +860.0% | −88.9% | 0.0% |
| 3 years | +29.6% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 and 3 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Transpact Enterprises competitors and peers
Medical Equipment & Supplies, 27 listed companies, priced on 30 Oct 2026. The table lists the 8 companies closest to Transpact Enterprises in market cap. 3 companies in the table last traded before then: their rows are priced on their last trade.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Choksi AsiaCHOKSI | 121 | 23.40 | 2.88 | +21.4% | – | 13.1% | 14.7% | 0.00% |
 Shree PacetronixSHREEPAC | 63 | 19.59 | 3.50 | +22.5% | +210.4% | 20.3% | 21.8% | 0.00% |
 Mohini Health & HygieneMHHL | 49 | – | 0.55 | −13.9% | −382.3% | −17.2% | – | 0.00% |
 Amkay ProductsAMKAY | 46 | 19.85 | 1.74 | +9.5% | −30.8% | 9.2% | – | 0.00% |
 Royal SenseROYAL | 40 | 5.53 | 0.98 | +67.5% | +13.0% | 21.0% | – | 0.00% |
 GKB OphthalmicsGKB | 29 | 9.06 | 0.56 | +29.9% | – | 6.2% | 10.5% | 0.00% |
 Galaxy MedicareGML | 27 | 7.99 | 0.68 | – | – | 8.5% | – | 3.89% |
 Centenial Surgical SutureCSURGSU | 26 | – | 0.91 | +6.7% | – | −4.8% | 5.3% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Transpact Enterprises announcements
Sep 2026
4 Sep · Board meeting
4 Sep · Board meeting
Transpact Enterprises share price by year
Each calendar year to 2025.Transpact Enterprises share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 137.90 | −33.6% | 297.50 | 120.00 |
| 2024 | 207.60 | −46.1% | 483.80 | 149.00 |
| 2023 | 385.00 | +150.8% | 385.00 | 95.00 |
| 2022 | 153.50 | −0.3% | 175.00 | 130.00 |
| 2021 | 154.00 | +18.5% | 176.50 | 129.00 |
| 2020 | 130.00 | −1.5% | 136.00 | 130.00 |
| 2019 | 132.00 | – | 136.00 | 130.50 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2022 is from its first session, 31 Jan 2022. 2020 is from its first session, 31 Jan 2020. 2019 is from its first session, 5 Sep 2019. The close is the year's last trade for 2021 (18 Nov 2021), 2020 (3 Nov 2020) and 2019 (19 Nov 2019).
Recent sessions
The 9 trading days to 29 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 29 Oct 2026 | 96.00 | 96.00 | 96.00 | 96.00 | 96.00 | 500 |
| 28 Oct 2026 | 95.00 | 105.00 | 95.00 | 96.00 | 98.17 | 4,500 |
| 27 Oct 2026 | 101.00 | 101.00 | 100.00 | 100.00 | 100.50 | 1,500 |
| 26 Oct 2026 | 100.50 | 100.50 | 100.50 | 100.50 | 100.50 | 500 |
| 19 Oct 2026 | 99.16 | 99.16 | 99.16 | 99.16 | 99.16 | 2,500 |
| 12 Oct 2026 | 94.44 | 94.44 | 94.44 | 94.44 | 94.44 | 1,000 |
| 8 Oct 2026 | 90.07 | 90.07 | 89.95 | 89.95 | 90.03 | 1,500 |
| 7 Oct 2026 | 85.79 | 85.79 | 85.79 | 85.79 | 85.79 | 17,000 |
| 22 Sep 2026 | 90.30 | 90.30 | 90.30 | 90.30 | 90.30 | 1,000 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 542765
- ISIN
- INE06YD01010
- Industry
- Healthcare Equipment & Supplies
- Website
- www.transpact.in
- CIN
- U66110MH2013PLC243247
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2013
- Registered office
- 204, Timmy Arcade, 2nd Floor, Makwana Road, Marol, Andheri East, Mumbai 400059, Maharashtra
- Share registrar
- Bigshare Services Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments